Avenue Therapeutics Ownership | Who Owns Avenue Therapeutics?

Avenue Therapeutics Ownership Summary

Avenue Therapeutics is owned by 1.12% institutional investors, and 98.88% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.32% of its assets in Avenue Therapeutics shares.

ATXI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Avenue Therapeutics	1.12%	-	98.88%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2023	1	-	25,000	-37.49%	1	34.79%	1	-	-	-
Mar 31, 2023	1	-	39,992	-	1	-	1	-	-	-
Jun 30, 2022	16	14.29%	673,937	-35.25%	3	12.46%	6	-25.00%	7	133.33%
Mar 31, 2022	14	-6.67%	1,040,903	-55.93%	4	2.44%	8	14.29%	3	-40.00%
Dec 31, 2021	15	-16.67%	2,361,894	116.90%	14	33.26%	7	-22.22%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	6.52K	0.32%	-71.00
Fidelity Series Total Market Index	1.58K	0.08%	-
Vanguard Institutional Extnd Mkt Idx Tr	618.00	0.03%	-
Spartan Extended Market Index Pool E	71.00	0.00%	71.00
NT Ext Equity Mkt Idx Fd - DC - NL - T2	6.00	0.00%	-
NT Ext Equity Mkt Idx Fd - L	6.00	0.00%	-
Northern Trust Extended Eq Market Idx	6.00	0.00%	-
NT Ext Equity Mkt Idx Fd - NL	7.00	0.00%	-
SSgA U.S. Extended Market Index Class I	193.00	0.00%	-
SSgA U.S. Total Market Index Strategy	1.00	0.00%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	2
2024 Q3	2	-
2024 Q2	-	-
2024 Q1	-	-

ATXI Ownership FAQ

Who Owns Avenue Therapeutics?

Avenue Therapeutics shareholders are primarily institutional investors at 1.12%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Avenue Therapeutics's industry, Biotech Stocks , is 68.48%, which Avenue Therapeutics falls below.

Does Blackrock own Avenue Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Avenue Therapeutics.

Who is the top mutual fund holder of Avenue Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Avenue Therapeutics shares, with 0.32% of its total shares outstanding invested in 6.52K Avenue Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools